These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 19117008)
1. Different roles of N- and C- termini in the functional activity of FGF21. Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008 [TBL] [Abstract][Full Text] [Related]
2. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. Kharitonenkov A; Dunbar JD; Bina HA; Bright S; Moyers JS; Zhang C; Ding L; Micanovic R; Mehrbod SF; Knierman MD; Hale JE; Coskun T; Shanafelt AB J Cell Physiol; 2008 Apr; 215(1):1-7. PubMed ID: 18064602 [TBL] [Abstract][Full Text] [Related]
3. FGF21 N- and C-termini play different roles in receptor interaction and activation. Yie J; Hecht R; Patel J; Stevens J; Wang W; Hawkins N; Steavenson S; Smith S; Winters D; Fisher S; Cai L; Belouski E; Chen C; Michaels ML; Li YS; Lindberg R; Wang M; Véniant M; Xu J FEBS Lett; 2009 Jan; 583(1):19-24. PubMed ID: 19059246 [TBL] [Abstract][Full Text] [Related]
4. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648 [TBL] [Abstract][Full Text] [Related]
5. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467 [TBL] [Abstract][Full Text] [Related]
6. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21. Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510 [TBL] [Abstract][Full Text] [Related]
7. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Kurosu H; Kuro-O M Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940 [TBL] [Abstract][Full Text] [Related]
8. The Klotho gene family and the endocrine fibroblast growth factors. Kurosu H; Kuro-o M Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672 [TBL] [Abstract][Full Text] [Related]
9. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho. Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560 [TBL] [Abstract][Full Text] [Related]
10. Mini-review: endocrine actions of fibroblast growth factor 19. Jones S Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175 [TBL] [Abstract][Full Text] [Related]
11. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664 [TBL] [Abstract][Full Text] [Related]
12. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Urakawa I; Yamazaki Y; Shimada T; Iijima K; Hasegawa H; Okawa K; Fujita T; Fukumoto S; Yamashita T Nature; 2006 Dec; 444(7120):770-4. PubMed ID: 17086194 [TBL] [Abstract][Full Text] [Related]
13. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602 [TBL] [Abstract][Full Text] [Related]
14. Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis. Phelps M; Stuelsatz P; Yablonka-Reuveni Z FEBS J; 2016 May; 283(9):1653-68. PubMed ID: 26881702 [TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical properties of fibroblast growth factor 23. Yamashita T Ther Apher Dial; 2005 Aug; 9(4):313-8. PubMed ID: 16076373 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a cell model expressing βKlotho for screening FGF21 analogues. Guo X; Wang X; Yuan Q; Wu C; Gao H; Xu P; Liu M; Wang N; Li D; Ren G Cytotechnology; 2019 Oct; 71(5):1033-1041. PubMed ID: 31535308 [TBL] [Abstract][Full Text] [Related]
17. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity. Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271 [TBL] [Abstract][Full Text] [Related]
18. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail. Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. Li X; Ge H; Weiszmann J; Hecht R; Li YS; Véniant MM; Xu J; Wu X; Lindberg R; Li Y FEBS Lett; 2009 Oct; 583(19):3230-4. PubMed ID: 19751733 [TBL] [Abstract][Full Text] [Related]